GLP-1 or dual receptor agonists such as semaglutide, or tirzepatide can make weight loss easier, but medication alone is rarely enough to sustain change. Without the right nutrition and activity support, weight loss can come from muscle as well as fat, nutrient intake may fall, and weight regain is common when treatment ends.

​

This programme helps you use the treatment period to protect muscle and bone, meet daily nutrient needs, and build habits that support long-term weight stability. Find out more about why support matters on GLP-1 agonists.

​​

How it works
Phase 1 – Foundation (first 12 weeks): We focus on balanced, nutrient-dense meals and regular strength-based movement to protect muscle, bone and health while appetite is reduced.
Phase 2 – Consolidation (months 3–12): As weight loss continues, we review progress, refine eating patterns, and focus on relapse-prevention skills. Physical activity is tailored to support muscle retention and metabolic health.
Phase 3 – Transition & maintenance (months 12–24 or sooner if tapered/stopped): When treatment is tapered or stopped, appetite usually increases and weight regain is common without continued support. We work on meal structure, portion regulation, and behavioural strategies to help you sustain results with confidence.​

​

Best for: Clients prescribed or considering GLP-1 receptor agonists within NHS or private medical care who want evidence-based nutrition, lifestyle and behavioural support to preserve muscle and bone, reduce nutrient deficiency risk, and prevent weight regain after treatment.

​Note:
Prescribing, dosage decisions, and monitoring of GLP-1 medications remain the responsibility of your doctor. My role is to provide nutrition, lifestyle and behaviour support alongside your medical team.